Riskpilot← Back to searchSign inGet full accessGobia Enterprises AB
ABActiveOrg 5566707534Södra Långebergsgatan 34-36Activities of holding companies · NACE 6421Est. 20040 employees
Revenue 2024
SEK 0
EBITDA margin
—
+57% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
SEK 476K
-49% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,1M | +57% |
| Net profit | SEK 476K | -49% |
| Total assets | SEK 362,1M | +0% |
| Equity | SEK 361,5M | +0% |
| Employees | 0 | — |
Legal name
Gobia Enterprises AB
Org number
5566707534
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
12 november 2004
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Södra Långebergsgatan 34-36
Email
jan.g.smith@circiuspharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 884 | −381 | −486 | −2 607 | −1 126 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 884 | −381 | −486 | −2 607 | −1 126 |
| Net financials | 42 | −14 010 | 94 088 | 3 783 | −1 531 |
| Profit before tax | 222 470 | −7 386 | 93 602 | 1 176 | 515 |
| Tax | −79 | −0 | −0 | −242 | −39 |
| Net profit | 222 391 | −7 386 | 93 602 | 934 | 476 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 273 961 | 266 488 | 360 117 | 361 295 | 362 092 |
| Equity | 273 874 | 266 488 | 360 090 | 361 024 | 361 500 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 88 | 0 | 28 | 271 | 593 |
| Total debt | 88 | — | 28 | 271 | 593 |
EBITDA margin
-112600000.0%
This company
15.8%
Market median
-712658328% vs market
20202024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
0.1%
This company
18.4%
Market median
-99% vs market
20202024
Net profit margin
47600000.0%
This company
8.1%
Market median
+587654221% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CP Chief Auditor | Chief Auditor | 2020 |
| Former (1) | ||
NM Chief Auditor | Chief Auditor | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2020 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gobia Enterprises AB (this company)
Roux Healthcare ABBoard members of Gobia Enterprises AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Magnus Götenfelt | Chief Auditor | 0 companies |
| Carl Patrik Resebo | Chief Auditor | 0 companies |
| Jan Erik Gustav Smith | Board of Directors | 0 companies |
| Jan Gustav Smith | Chairman | 0 companies |
| Leif Carl Gustav Smith | Board of Directors | 0 companies |
| Ingrid Eva Margareta Smith | Deputy Board Member | 0 companies |
| Eric Carl Gustav Smith | Deputy Board Member | 0 companies |